MUMBAI (NewsRise) -- Sun Pharmaceutical Industries, India's largest drug maker, reported a quarterly profit that beat analysts' estimates, aided by its exclusive launch of a generic cancer drug in the U.S., but smaller rival Cipla said net income nearly halved from last year.
Business